BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamilton JP. Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics 2010;2:233-43. [PMID: 20556199 DOI: 10.2217/epi.10.9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Koturbash I, Melnyk S, James SJ, Beland FA, Pogribny IP. Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Mol Carcinog. 2013;52:318-327. [PMID: 22213190 DOI: 10.1002/mc.21861] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
2 Fujiwara H, Takahara N, Tateishi K, Tanaka M, Kanai S, Kato H, Nakatsuka T, Yamamoto K, Kogure H, Arita J, Nakai Y, Kasuga M, Ushiku T, Hasegawa K, Koike K. 5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids. Surg Oncol 2020;35:484-90. [PMID: 33126085 DOI: 10.1016/j.suronc.2020.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jiang K, Al-Diffhala S, Centeno BA. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Cancer Control. 2018;25:1073274817744625. [PMID: 29350068 DOI: 10.1177/1073274817744625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
4 Hamilton JP. Epigenetics: principles and practice. Dig Dis 2011;29:130-5. [PMID: 21734376 DOI: 10.1159/000323874] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
5 Tian M, Zhao B, Zhang J, Martin FL, Huang Q, Liu L, Shen H. Association of environmental benzo[a]pyrene exposure and DNA methylation alterations in hepatocellular carcinoma: A Chinese case-control study. Sci Total Environ. 2016;541:1243-1252. [PMID: 26476064 DOI: 10.1016/j.scitotenv.2015.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
6 Raggi C, Invernizzi P. Methylation and liver cancer. Clin Res Hepatol Gastroenterol 2013;37:564-71. [PMID: 23806627 DOI: 10.1016/j.clinre.2013.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ali Kamkar MM, Ahmad R, Alsmadi O, Behbehani K. Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review. J Diabetes Metab Disord. 2014;13:57. [PMID: 24918094 DOI: 10.1186/2251-6581-13-57] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
8 Jiang K, Centeno BA. Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis. Cancer Control 2018;25:1073274817744658. [PMID: 29353494 DOI: 10.1177/1073274817744658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
9 Nie J, Zhang J, Wang L, Lu L, Yuan Q, An F, Zhang S, Jiao Y. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4. J Exp Clin Cancer Res 2017;36:183. [PMID: 29237483 DOI: 10.1186/s13046-017-0641-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wolinska E, Skrzypczak M. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4237. [PMID: 34439391 DOI: 10.3390/cancers13164237] [Reference Citation Analysis]
11 Lu J, Hsia Y, Tu H, Hsiao Y, Yang W, Wang H, Yuh C. Liver development and cancer formation in zebrafish. Birth Defects Research Part C: Embryo Today: Reviews 2011;93:157-72. [DOI: 10.1002/bdrc.20205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
12 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
13 Maemura K, Natsugoe S, Takao S. Molecular mechanism of cholangiocarcinoma carcinogenesis. J Hepatobiliary Pancreat Sci 2014;21:754-60. [DOI: 10.1002/jhbp.126] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
14 Martin M, Herceg Z. From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med. 2012;4:8. [PMID: 22293089 DOI: 10.1186/gm307] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]